Connect with us

Technology

Cerebral And Tissue Oximetry Devices Market size is set to grow by USD 96.3 million from 2024-2028, Growing use of cerebral and tissue oximetry devices in cardiac surgical procedures boost the market, AI Role and Impact, Technavio

Published

on

NEW YORK, Aug. 22, 2024 /PRNewswire/ — The global cerebral and tissue oximetry devices market size is estimated to grow by USD 96.3 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  8.08%  during the forecast period. Growing use of cerebral and tissue oximetry devices in cardiac surgical procedures is driving market growth, with a trend towards technological advances in cerebral and tissue oximetry devices. However, high cost of cerebral and tissue oximetry devices  poses a challenge. Key market players include Artinis Medical Systems, Boston Scientific Corp., Edwards Lifesciences Corp., GE Healthcare Technologies Inc., Hamamatsu Photonics KK, HyperMed Imaging Inc., ISS Inc., Masimo Corp., Medtronic Plc, Moor Instruments Ltd., Nonin Medical Inc., Sotera Health Co., Spectros Medical Devices Inc., Terumo Corp., and ViOptix Inc..

Get a detailed analysis on regions, market segments, customer landscape, and companies- View the snapshot of this report

Cerebral And Tissue Oximetry Devices Market Scope

Report Coverage

Details

Base year

2023

Historic period

2018 – 2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 8.08%

Market growth 2024-2028

USD 96.3 million

Market structure

Concentrated

YoY growth 2022-2023 (%)

7.3

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 37%

Key countries

US, China, Germany, France, and Japan

Key companies profiled

Artinis Medical Systems, Boston Scientific Corp., Edwards Lifesciences Corp., GE Healthcare Technologies Inc., Hamamatsu Photonics KK, HyperMed Imaging Inc., ISS Inc., Masimo Corp., Medtronic Plc, Moor Instruments Ltd., Nonin Medical Inc., Sotera Health Co., Spectros Medical Devices Inc., Terumo Corp., and ViOptix Inc.

Market Driver

The cerebral and tissue oximetry devices market is witnessing significant advancements, driven by vendors’ focus on offering innovative products with enhanced features and benefits. Technological progressions, such as the adoption of diffuse correlation spectroscopy (DCS) technology for sensitive and rapid blood flow measurements and cerebral metabolism ratio of oxygen in deeply located tissues, are key factors fueling market growth. Vendors are also integrating continuous-wave light sources instead of pulsed laser and frequency-modulated approaches to reduce costs. Notable technology offerings include Medtronic’s INVOS TECHNOLOGY, which provides multi-sensor monitoring and real-time data on the balance of oxygen supply and demand using a 3:1 ratio of venous and arterial blood. Edward Lifesciences’ LASER-SIGHT optical technology increases the accuracy and reliability of cerebral and tissue oximetry devices by using five precise wavelengths of NIRS. Nonin Medical’s EQUANOX technology offers six channels for simultaneous monitoring of peripheral oxygen saturation (SpO2) and rSO2, along with dual detector and dual emitter sensors for enhanced accuracy. These advancements in NIRS technologies are crucial for end-users seeking precise and accurate measurements for routine healthcare operations. The increasing adoption of cerebral and tissue oximetry devices is expected to significantly boost the growth of the global cerebral and tissue oximetry devices market during the forecast period. 

The Cerebral and Tissue Oximetry Devices market is witnessing significant growth due to the increasing focus on monitoring oxygen saturation levels in various medical settings. Minimally invasive procedures using portable cerebral oximeter monitors are becoming popular among physicians for measuring cerebral oxygenation levels in cerebral tissues. These devices use sensors, a cable, oximeter probe, and a light detector with a fiber-optic light source to measure oxygen levels in the brain. The geriatric population and those with neurodegenerative diseases are major users of these devices. Oxygen saturation monitoring is essential during surgeries, ICUs, research settings, neonatal care, and for premature infants. Sensor technologies and data analytics are trending in this market, enabling real-time monitoring and improved patient care. Cerebral oximetry devices are used to monitor oxygen saturation levels in muscles, liver, and other tissues, besides the brain. These devices are available as tabletop models and portable, handheld units, catering to diverse requirements in hospitals and other healthcare facilities. 

Explore a 360° Analysis of the Market: Unveil the Impact of AI. For complete insights- Request Sample!

Market Challenges

The cost is a crucial factor for end-users when purchasing cerebral and tissue oximetry devices. The expense related to components and overall system hardware, including monitors, sensors, mounting options, and maintenance, significantly influences their buying decision. Advanced technologies, such as Near Infrared Spectroscopy (NIRS), used in these devices for accurate blood oxygenation monitoring, increase the overall cost. Monitors range from USD12,000 to USD25,000, and mounting options like wall mounts and roll stands can cost up to USD1,000. Sensor costs vary, with adult sensors priced between USD50 and USD100, and pediatric/infant sensors costing USD100USD150. Maintenance costs, primarily battery replacements, range from USD450 to USD550. Large-scale hospitals and clinical settings can justify these investments, but small healthcare facilities face challenges justifying the costs, potentially hindering the adoption and growth of the global cerebral and tissue oximetry devices market.The Cerebral and Tissue Oximetry Devices market is witnessing significant growth due to the increasing demand for non-invasive monitoring of oxygen saturation levels in various medical settings. These devices use sensors to measure tissue oxygen levels in muscles, liver, and during surgeries in ICUs, research settings, neonatal care, and premature infants. Sensor technologies and data analytics play a crucial role in providing real-time data for surgical procedures in operating rooms and outpatient settings. However, high device costs and complex reimbursement policies pose challenges to market growth. User-friendly design, portability, and flexibility are essential features for end-users. Tabletop devices are common in hospitals, while handheld devices offer convenience for healthcare professionals in diverse medical specialties, including neurological conditions, cardiovascular disorders, and heart disease. AI integration, wireless connectivity, and data analysis capabilities are emerging trends, enabling home healthcare and mobile monitoring systems for chronic diseases like peripheral artery disease. Surgeons and healthcare professionals rely on these devices for real-time data during surgeries, enhancing patient safety and outcomes.

For more insights on driver and challenges – Request a sample report!

Segment Overview 

This cerebral and tissue oximetry devices market report extensively covers market segmentation by  

Product 1.1 Modular devices1.2 Handheld devicesEnd-user 2.1 Hospitals2.2 ClinicsGeography 3.1 North America3.2 Europe3.3 Asia3.4 Rest of World (ROW)

1.1 Modular devices-  Handheld cerebral and tissue oximetry devices are compact, next-generation tools that provide instantaneous oxygen level measurements in blood without requiring direct patient contact or external connections to sensors and monitors. Advanced compatibility features enable these devices to pair with modular offerings from vendors, creating comprehensive solutions for medical practitioners during pre-operative, intra-operative, and postoperative assessments. Paired devices allow for real-time monitoring and decision-making during surgeries, saving valuable time. Proprietary spectrometer technology, such as HyperMed Imaging’s HyperView and ViOptix’s Intra.Ox, sets handheld devices apart from standard-of-care diagnostic imaging tools, which cannot distinguish oxygenated and deoxygenated hemoglobin. This advantage, along with applications in vascular procedures, wound care, and reconstructive surgeries, is fueling market growth for handheld cerebral and tissue oximetry devices.

For more information on market segmentation with geographical analysis including forecast (2024-2028) and historic data (2017-2021) – Download a Sample Report

Research Analysis

Cerebral and tissue oximetry devices measure oxygen saturation levels in cerebral tissues, including muscles and the liver. These devices are essential in various settings such as surgeries in ICUs, research settings, neonatal care for premature infants, and outpatient settings. Surgical procedures and operating rooms particularly benefit from real-time monitoring of cerebral oxygenation levels to ensure optimal patient care. High device costs and complex reimbursement policies pose challenges to widespread adoption. Advancements in technology include AI integration and wireless connectivity, enabling seamless integration into medical specialties treating chronic diseases and neurological conditions. Physicians rely on cerebral oximeter monitors, which include a cable and oximeter probe, typically placed on the forehead area. The device utilizes a light detector and fiber-optic light source to assess oxygen saturation levels in cerebral tissues.

Market Research Overview

Cerebral and tissue oximetry devices are non-invasive tools used to measure oxygen saturation levels in various tissues, including muscles, liver, and cerebral tissues. These devices use sensors to detect the amount of oxygen in the tissue based on the amount of light absorbed. They are used in various settings such as surgeries, ICUs, research settings, neonatal care, and home healthcare. Premature infants and patients with chronic diseases, neurological conditions, and cardiovascular disorders benefit from these devices. Sensor technologies have advanced to include data analytics, AI integration, and wireless connectivity, making them user-friendly, portable, and flexible. Handheld devices and tabletop devices are popular due to their portability and real-time data capabilities. High device costs and reimbursement policies are challenges in the market. These devices are used in surgical procedures, operating rooms, outpatient settings, and minimally invasive procedures. Surgeons and healthcare professionals rely on cerebral oximeter monitors to monitor cerebral oxygenation levels in the brain, especially during cardiac surgeries and cardiovascular diseases. Geriatric population with neurodegenerative diseases also benefits from these devices. Oxygen saturation levels are essential indicators of tissue health, and these devices provide valuable information for medical specialties to make informed decisions.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

ProductModular DevicesHandheld DevicesEnd-userHospitalsClinicsGeographyNorth AmericaEuropeAsiaRest Of World (ROW)

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/cerebral-and-tissue-oximetry-devices-market-size-is-set-to-grow-by-usd-96-3-million-from-2024-2028–growing-use-of-cerebral-and-tissue-oximetry-devices-in-cardiac-surgical-procedures-boost-the-market-ai-role-and-impact-technavio-302228668.html

SOURCE Technavio

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

ADX welcomes Morgan Stanley as the first international investment bank Remote Trading Member, expanding global access to Abu Dhabi’s capital markets

Published

on

By

ABU DHABI, UAE, May 5, 2026 /PRNewswire/ — The Abu Dhabi Securities Exchange (ADX) Group today announced that Morgan Stanley, a leading investment bank and financial services company, has joined the ADX as its first international investment bank Remote Trading Member — enabling Morgan Stanley’s clients to access the ADX directly.

This milestone strengthens ADX’s global connectivity and supports growing international institutional demand for exposure to UAE markets. It also reinforces its position as one of the world’s fastest-growing exchanges by market capitalization, while highlighting the market’s continued progress in depth, liquidity, and inclusion in major global indices.

Remote membership enables Morgan Stanley to provide its clients with direct market access to the ADX, with trading conducted via the firm’s global trading platform. The ADX continues to play a pivotal role in advancing Abu Dhabi’s long-term economic ambitions, as a mechanism for a diversified, innovation-led, knowledge-based economy.

Morgan Stanley’s direct trading access to ADX reflects the strength of Abu Dhabi’s investment proposition and the continued institutionalization of UAE capital markets. Morgan Stanley’s membership will enhance execution quality, optimize order routing, and provide greater control across the end-to-end trade lifecycle, delivering an advanced trading experience for global investors.

The structure follows a proven international access model used by Morgan Stanley and is designed to meet growing client demand for efficient, transparent, and seamless access to ADX-listed opportunities.

Abdulla Salem Alnuaimi, Group Chief Executive Officer of Abu Dhabi Securities Exchange (ADX) Group, said: “This marks a significant step in advancing our ambition to be a leading financial marketplace that drives opportunity and sustainable economic growth. This momentum is reflected in the strong foreign investor participation, with trading value exceeding 85 billion dirhams in the first quarter of 2026 up by 22% year on year. This performance underscores the growing depth and global relevance of our market, while reinforcing our commitment to expanding international access, strengthening cross-border connectivity, and building a world-class market infrastructure that attracts global capital, supports a diverse range of issuers and contributes to Abu Dhabi’s long-term economic prosperity.”

Patrick Delivanis, Regional Co-Head of MENA at Morgan Stanley, said: “Becoming a Remote Trading Member of ADX reflects our focus on providing clients with efficient, seamless access to Abu Dhabi’s capital markets through our market–leading trading platform. We see continued momentum in the institutionalization and international participation of UAE markets, and we’re pleased to support that evolution by enabling international investors to access opportunities in MENA with direct connectivity to local markets, alongside greater transparency and control across the trading lifecycle.”

Morgan Stanley’s participation aligns with ADX’s strategy to strengthen international connectivity, with remote memberships selectively offered to global firms to attract high-quality cross-border liquidity. The announcement builds on the ADX’s expansion momentum: in 2025, foreign investment rose by nearly 14% and institutional trading increased by 10% year on year. Subject to final operational readiness, Morgan Stanley expects to begin trading as a remote member in the coming weeks.

About Abu Dhabi Securities Exchange (ADX)

The Abu Dhabi Securities Exchange (ADX) was established on 15 November 2000 pursuant to Local Law No. (3) of 2000, which granted the exchange legal rights with independent financial and administrative status, as well as the necessary supervisory and executive powers necessary to carry out its functions. On 17 March 2020, the ADX was converted from a public entity into a Public Joint Stock Company (PJSC) in accordance with Law No. (8) of 2020.

The ADX Group, a market infrastructure group comprising the exchange (ADX) and its post-trade ecosystem, including its wholly owned subsidiaries AD Depository and AD Clear, was established. Through its integrated and globally aligned business structure, the ADX Group supports efficient, transparent, and resilient capital markets across trading, clearing, settlement, and custody.

The Group provides an efficient and regulated marketplace for the trading of securities, including equities issued by public joint-stock companies, bonds issued by governments and corporations, exchange-traded funds (ETFs), and other financial instruments approved by the UAE Capital Market Authority.

The ADX is the second-largest exchange in the Arab region by market capitalization. Its strategy of delivering stable financial performance through diversified revenue streams is aligned with the UAE’s national development agenda, “Towards the Next 50”, which aims to build a sustainable, diversified, and high-value-added economy.

For more information, please contact:
Abdulrahman Saleh ALKhateeb
Manager of Corporate Communication
Abu Dhabi Securities Exchange (ADX)
Mobile: +971 (50) 668 9733
Email: ALKhateebA@adx.ae

 

 

View original content:https://www.prnewswire.com/apac/news-releases/adx-welcomes-morgan-stanley-as-the-first-international-investment-bank-remote-trading-member-expanding-global-access-to-abu-dhabis-capital-markets-302762404.html

SOURCE Abu Dhabi Securities Exchange (ADX)

Continue Reading

Technology

Geotab integrates Polestar vehicles into its OEM telematics network

Published

on

By

Fleet operators across North America, Europe, and APAC can now access Polestar vehicle data directly in MyGeotab — no aftermarket hardware required.

LONDON, UK, May 5, 2026 /PRNewswire/ — Geotab, a global leader in connected vehicle and asset management solutions, today announced the integration of Polestar vehicles into its OEM telematics network, giving commercial fleet operators seamless access to Polestar data within MyGeotab from day one — with no aftermarket hardware installation required. The integration is available globally across North America, Europe, and Asia Pacific, supporting all Polestar models.

Developed in collaboration with Geotab, among other telematics service providers, Polestar Fleet Telematics integrates directly into MyGeotab. The Geotab integration enables fleet managers to manage Polestar vehicles alongside all other makes and models on a single unified platform — without fitting additional devices.

Connected vehicle data where it matters most

Through Polestar Fleet Telematics, fleet operators gain near-real-time access to a comprehensive dataset — covering EV battery and charging status, location, tyre information, vehicle security, maintenance alerts, and climate data — flowing directly from Polestar’s connected vehicle architecture into MyGeotab, with no physical installation required.

This breadth of data enables fleet managers to move from reactive to proactive operations — scheduling maintenance before failures occur, optimising charge planning across depots, and maintaining duty-of-care oversight across the entire fleet.

Supporting Europe’s Mixed-Fleet Reality

OEM-embedded telematics removes the need for aftermarket device installation across mixed-manufacturer fleets, reducing logistical overhead and supporting compliance with works council and GDPR requirements — a critical consideration for European fleet operators.

“Polestar Fleet Telematics combines sustainability with intelligence, integrating seamlessly with Geotab to deliver these capabilities directly into the platforms fleet operators trust. Continuous data visibility enables more efficient and informed fleet operations, from day-to-day management to long-term planning. By leveraging Polestar vehicles’ embedded connectivity, fleet managers can make smarter, data-driven decisions — without adding hardware or complexity to their operations.” said Emma Knapp, Manager of Global Key Accounts at Polestar.

Polestar joins an OEM telematics network that already spans over 80% of leading global vehicle manufacturers by fleet market share, including BMW Group, Ford, Stellantis, Volkswagen Group, and Volvo Cars. For fleet operators already using MyGeotab, Polestar vehicles can be connected and deliver data without any additional hardware or installation.

“OEM-embedded telematics represents a change in how fleet data reaches the platform — and Polestar’s connected vehicle architecture makes this integration particularly well-suited for markets that are seriously considering transitioning to electric vehicles.” said Christoph Ludewig, Vice President OEM Global at Geotab. “Fleet operators managing mixed EV and internal combustion engine fleets no longer need separate tools or hardware for each vehicle type. Polestar data flows directly into MyGeotab alongside every other vehicle in the fleet — giving operators the consolidated visibility they need to drive efficiency, support duty of care, and manage their EV transition with confidence.”

Global Availability

The integration is available now across North America, Europe, and Asia Pacific, supporting all Polestar models. Fleet managers can activate the service via the Geotab Marketplace or by contacting their Geotab representative.

About Polestar

Polestar (Nasdaq: PSNY) is the Swedish electric performance car brand with a focus on uncompromised design and innovation, and the ambition to accelerate the change towards a sustainable future. Headquartered in Gothenburg, Sweden, its cars are available in 28 markets globally across North America, Europe and Asia Pacific.

Polestar has four models in its line-up: Polestar 2, Polestar 3, Polestar 4, and Polestar 5. Planned models include the Polestar 7 compact SUV (to be introduced in 2028) and the Polestar 6 roadster. With its vehicles currently manufactured on two continents, North America and Asia, Polestar plans to diversify its manufacturing footprint further, with production of Polestar 7 planned in Europe.

Polestar has an unwavering commitment to sustainability and has set an ambitious roadmap to reach its climate targets: halve greenhouse gas emissions by 2030 per-vehicle-sold and become climate-neutral across its value chain by 2040. Polestar’s comprehensive sustainability strategy covers the four areas of Climate, Transparency, Circularity, and Inclusion.

About Geotab

Geotab is a global leader in connected vehicle and asset management solutions, with headquarters in Oakville, Ontario and Atlanta, Georgia. Our mission is to make the world safer, more efficient, and sustainable. We leverage advanced data analytics and AI to transform fleet performance and operations, reducing cost and driving efficiency. Backed by top data scientists and engineers, we serve approximately 100,000 global customers, processing 100 billion data points daily from more than 5 million vehicle subscriptions. Geotab is trusted by Fortune 500 organisations, mid-sized fleets, and the largest public sector fleets in the world, including the US Federal government. Committed to data security and privacy, we hold FIPS 140-3 and FedRAMP authorisations. Our open platform, ecosystem of outstanding partners, and Geotab Marketplace deliver hundreds of fleet-ready third-party solutions. This year, we’re celebrating 25 years of innovation. Learn more at www.geotab.com/uk and follow us on LinkedIn or visit our blog.

GEOTAB and GEOTAB MARKETPLACE are registered trademarks of Geotab Inc. in Canada, the United States and/or other countries.

Media Contact: Geotab Contact, Romina Dashghachian, Strategic Communications Lead, EMEA, pr@geotab.com

Photo – https://mma.prnewswire.com/media/2972188/Geotab_Inc__Geotab_integrates_Polestar_vehicles_into_its_OEM_tel.jpg 
Logo – https://mma.prnewswire.com/media/2972187/Geotab_Inc__Geotab_integrates_Polestar_vehicles_into_its_OEM_tel.jpg 

 

View original content:https://www.prnewswire.co.uk/news-releases/geotab-integrates-polestar-vehicles-into-its-oem-telematics-network-302761910.html

Continue Reading

Technology

IDX Opens Geneva Office and Strengthens Global Data & Insights Capability

Published

on

By

New Swiss presence and specialist team integration support growing global demand for evidence-based, defensible communications strategies

LONDON, May 5, 2026 /PRNewswire/ — IDX today announced the opening of its new Geneva office and the integration of a specialist Data & Insights team, strengthening the company’s international footprint and expanding its ability to help clients worldwide build communications strategies grounded in evidence, market intelligence and audience insight.

The expansion gives IDX an on-the-ground presence in Switzerland while adding further depth to its Data & Insights capability. The Geneva-based team will work closely with IDX specialists across performance marketing and corporate communications, helping clients develop a clearer view of the markets they operate in and the forces shaping their growth.

The move aligns with Destination 250 – Customers First, IDX’s global strategy to grow its team by 250, focused on deepening client value, strengthening delivery and investing in the capabilities that matter most to clients.

The investment strengthens the Data pillar of IDX’s Connected Content™ model, which combines Creative, Data, Technology and Media to create what IDX calls The Multiplier Effect, helping clients multiply what matters through more connected, measurable and effective work.

“IDX is experiencing phenomenal growth, and our new Geneva office gives us boots on the ground to better serve clients across Europe and globally across performance marketing, investor relations and corporate communications,” said Crispin Beale, Worldwide CEO, IDX. “Data has been at the heart of this business for decades, and this centre of excellence reflects our continued investment in that capability. It’s an incredibly exciting time for IDX, and I look forward to the next phase of our growth as we continue to expand globally.”

“This is an exciting step in IDX’s growth story and a clear response to what clients are asking for: more evidence-based thinking, stronger market context and clearer rationale behind their communications strategies,” said Chris Corrigan, Chief Customer Growth Officer, IDX. “Our new presence in Geneva, combined with deeper Data & Insights expertise, strengthens the way we support clients globally, giving them earlier access to the insight and market context they need to make better-informed decisions and turn evidence into action.”

The Geneva office will strengthen relationships with existing clients in the region, support re-engagement with former partners and create new opportunities for IDX with organisations operating across European and global markets. It reflects IDX’s continued investment in the capabilities that matter most to clients as communications, marketing and corporate reputation work become increasingly data-led and commercially accountable.

“IDX’s integrated offer across insights, performance marketing and corporate communications, powered by the combination of human intelligence, advanced technology and AI, represents exactly where the industry is heading,” said Lonneke de Roo, Head of Data & Insights, IDX. “I am delighted to join the business and help clients navigate increasingly complex markets with clearer evidence, sharper insight and more connected strategies.”

ABOUT IDX  

IDX is a global strategic communications and marketing agency, headquartered in London with offices around the world, including New York, London, Phoenix, Helsinki, Gothenburg, Geneva, and Vadodara. Working with more than 1,600 clients across sectors, IDX combines deep industry knowledge with a data-first mindset to help ambitious brands thrive in complex, fast-moving markets. The firm specialises in performance marketing, investor relations, and stakeholder engagement, delivering integrated campaigns that drive meaningful business outcomes. Visit www.idx.inc to learn more.

Logo – https://mma.prnewswire.com/media/2668561/IDX_black_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/idx-opens-geneva-office-and-strengthens-global-data–insights-capability-302762181.html

Continue Reading

Trending